{"DataElement":{"publicId":"5698599","version":"1","preferredName":"WHO 2016 Classification of Diffuse Astrocytoma And Oligodendroglial Tumors Name","preferredDefinition":"Text term to represent the name of the 2016 WHO (World Health Organization) classification of a brain tumor.","longName":"WHO_DAST_OLG_TMR_NM","context":"ABTC","contextVersion":"1","DataElementConcept":{"publicId":"5698548","version":"1","preferredName":"WHO Classification of Tumors Diffuse Astrocytoma And Oligodendroglial Tumor","preferredDefinition":"A classification of benign and malignant tumors by World Health Organization (WHO) experts based primarily on histologic findings._A low-grade (WHO grade II) astrocytic neoplasm. It is characterized by diffuse infiltration of neighboring central nervous system structures. These lesions typically affect young adults and have a tendency for progression to anaplastic astrocytoma and glioblastoma. Based on the IDH genes mutation status, diffuse astrocytomas are classified as IDH-mutant, IDH-wildtype, and not otherwise specified._An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._A neoplasm of the central nervous system composed predominantly of cells morphologically resembling oligodendroglia.  Oligodendroglial tumors histologically comprise a continuous spectrum ranging from well-differentiated neoplasms to frankly malignant tumors. WHO grading system recognizes two malignancy grades: WHO grade II for well-differentiated tumors (oligodendroglioma) and WHO grade III for anaplastic oligodendroglioma. (Adapted from WHO)","longName":"5210896v1.0:5698546v1.0","context":"ABTC","contextVersion":"1","ObjectClass":{"publicId":"5210896","version":"1","preferredName":"WHO Classification of Tumors","preferredDefinition":"A classification of benign and malignant tumors by World Health Organization (WHO) experts based primarily on histologic findings.","longName":"C113304","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"WHO Classification of Tumors","conceptCode":"C113304","definition":"A classification of benign and malignant tumors by World Health Organization (WHO) experts based primarily on histologic findings.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FC19F3A-FB6B-BEEA-E050-BB89AD436723","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"ONEDATA","dateModified":"2016-04-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5698546","version":"1","preferredName":"Diffuse Astrocytoma And Oligodendroglial Tumor","preferredDefinition":"A low-grade (WHO grade II) astrocytic neoplasm. It is characterized by diffuse infiltration of neighboring central nervous system structures. These lesions typically affect young adults and have a tendency for progression to anaplastic astrocytoma and glioblastoma. Based on the IDH genes mutation status, diffuse astrocytomas are classified as IDH-mutant, IDH-wildtype, and not otherwise specified.:An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.:A neoplasm of the central nervous system composed predominantly of cells morphologically resembling oligodendroglia.  Oligodendroglial tumors histologically comprise a continuous spectrum ranging from well-differentiated neoplasms to frankly malignant tumors. WHO grading system recognizes two malignancy grades: WHO grade II for well-differentiated tumors (oligodendroglioma) and WHO grade III for anaplastic oligodendroglioma. (Adapted from WHO)","longName":"C7173:C37912:C6960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diffuse Astrocytoma","conceptCode":"C7173","definition":"A low-grade (WHO grade 2) astrocytic neoplasm. It is characterized by diffuse infiltration of neighboring central nervous system structures. These lesions typically affect young adults and have a tendency for progression to anaplastic astrocytoma and glioblastoma. Based on the IDH genes mutation status, diffuse astrocytomas are classified as IDH-mutant, IDH-wildtype, and not otherwise specified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Oligodendroglial Tumor","conceptCode":"C6960","definition":"A neoplasm of the central nervous system composed predominantly of cells morphologically resembling oligodendroglia.  Oligodendroglial tumors histologically comprise a continuous spectrum ranging from well-differentiated neoplasms to frankly malignant tumors. WHO grading system recognizes two malignancy grades: WHO grade 2 for well-differentiated tumors (oligodendroglioma) and WHO grade 3 for anaplastic oligodendroglioma. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A2C789B-C99B-0F32-E053-F662850A250A","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"ONEDATA","dateModified":"2017-03-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A2C789B-C9AC-0F32-E053-F662850A250A","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"COOPERM","dateModified":"2017-03-10","changeDescription":"Created for ABTC-1601 study in Rave. mc 3/7/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5698552","version":"1","preferredName":"WHO 2016 Diffuse Astrocytic and Oligodendroglial Tumors Name","preferredDefinition":"The words or language units by which a thing is known.","longName":"WHO_2016_BRN_TMR_NM","context":"ABTC","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"65","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Oligodendroglioma, NOS","valueDescription":"Oligodendroglioma, Not Otherwise Specified","ValueMeaning":{"publicId":"5698554","version":"1","preferredName":"Oligodendroglioma, Not Otherwise Specified","longName":"5698554","preferredDefinition":"An oligodendroglioma in which there is insufficient information on the IDH genes and 1p/19q codeletion status.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oligodendroglioma, Not Otherwise Specified","conceptCode":"C129319","definition":"A central nervous system tumor with morphological features of oligodendroglioma in which there is insufficient information on the IDH genes and 1p/19q codeletion status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A2D2B82-B1D1-2EE0-E053-F662850A413A","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4A2D2B82-B1EA-2EE0-E053-F662850A413A","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"ONEDATA","dateModified":"2017-03-07","deletedIndicator":"No"},{"value":"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted","valueDescription":"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted","ValueMeaning":{"publicId":"5698556","version":"1","preferredName":"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted","longName":"5698556","preferredDefinition":"An oligodendroglioma carrying IDH gene family mutation and combined whole-arm losses of 1p and 19q (1p/19q codeletion).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted","conceptCode":"C129318","definition":"An oligodendroglioma carrying IDH gene family mutation and combined whole-arm losses of 1p and 19q (1p/19q codeletion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A2D2B82-B1F7-2EE0-E053-F662850A413A","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4A2D2B82-B210-2EE0-E053-F662850A413A","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"ONEDATA","dateModified":"2017-03-07","deletedIndicator":"No"},{"value":"Oligoastrocytoma, NOS","valueDescription":"Oligoastrocytoma, Not Otherwise Specified","ValueMeaning":{"publicId":"5698558","version":"1","preferredName":"Oligoastrocytoma, Not Otherwise Specified","longName":"5698558","preferredDefinition":"A diffuse glioma characterized by the presence of both an astrocytic and an oligodendroglial component and the absence of information on the IDH genes status.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oligoastrocytoma, Not Otherwise Specified","conceptCode":"C129323","definition":"A central nervous system tumor with morphological features of oligoastrocytoma in which there is insufficient information on the IDH genes status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A2D2B82-B21D-2EE0-E053-F662850A413A","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4A2D2B82-B236-2EE0-E053-F662850A413A","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"ONEDATA","dateModified":"2017-03-07","deletedIndicator":"No"},{"value":"Gliosarcoma","valueDescription":"Gliosarcoma","ValueMeaning":{"publicId":"2578705","version":"1","preferredName":"Gliosarcoma","longName":"2578705","preferredDefinition":"A rare histological variant of glioblastoma (WHO grade IV) characterized by a biphasic tissue pattern with alternating areas displaying glial and mesenchymal differentiation (WHO).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gliosarcoma","conceptCode":"C3796","definition":"A rare histological variant of glioblastoma (WHO grade IV) characterized by a biphasic tissue pattern with alternating areas displaying glial and mesenchymal differentiation (WHO).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-007E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"COOPERM","dateModified":"2017-03-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4A2D2B82-B240-2EE0-E053-F662850A413A","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"ONEDATA","dateModified":"2017-03-07","deletedIndicator":"No"},{"value":"Glioblastoma, NOS","valueDescription":"Glioblastoma, Not Otherwise Specified","ValueMeaning":{"publicId":"5698560","version":"1","preferredName":"Glioblastoma, Not Otherwise Specified","longName":"5698560","preferredDefinition":"Glioblastoma in which there is insufficient information on the IDH genes status.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glioblastoma, Not Otherwise Specified","conceptCode":"C129295","definition":"A central nervous system tumor with morphological features of glioblastoma in which there is insufficient information on the IDH genes status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A2D2B82-B24D-2EE0-E053-F662850A413A","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4A2D2B82-B266-2EE0-E053-F662850A413A","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"ONEDATA","dateModified":"2017-03-07","deletedIndicator":"No"},{"value":"Glioblastoma, IDH-wildtype","valueDescription":"Glioblastoma, IDH-Wildtype","ValueMeaning":{"publicId":"5698562","version":"1","preferredName":"Glioblastoma, IDH-Wildtype","longName":"5698562v1.00","preferredDefinition":"A glioblastoma that arises de novo. It is more commonly seen in older patients. Mutations in IDH1 or IDH2 genes are not present.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glioblastoma, IDH-Wildtype","conceptCode":"C39750","definition":"A glioblastoma that arises de novo. It is more commonly seen in older patients. Mutations in IDH1 or IDH2 genes are not present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A2D2B82-B273-2EE0-E053-F662850A413A","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4A2D2B82-B28C-2EE0-E053-F662850A413A","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"ONEDATA","dateModified":"2017-03-07","deletedIndicator":"No"},{"value":"Glioblastoma, IDH-mutant","valueDescription":"Glioblastoma, IDH-Mutant","ValueMeaning":{"publicId":"5698564","version":"1","preferredName":"Glioblastoma, IDH-Mutant","longName":"5698564","preferredDefinition":"A glioblastoma arising from a lower grade astrocytoma.  It is more commonly seen in younger patients and is associated with IDH1 or IDH2 gene mutations.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Secondary Glioblastoma","conceptCode":"C39751","definition":"A glioblastoma arising from a lower grade astrocytoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A2D2B82-B299-2EE0-E053-F662850A413A","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4A2D2B82-B2B2-2EE0-E053-F662850A413A","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"ONEDATA","dateModified":"2017-03-07","deletedIndicator":"No"},{"value":"Giant cell glioblastoma","valueDescription":"Giant Cell Glioblastoma","ValueMeaning":{"publicId":"2578703","version":"1","preferredName":"Giant Cell Glioblastoma","longName":"2578703","preferredDefinition":"A rare histological variant of Glioblastoma (WHO grade IV) with a predominance of bizarre, multinucleated giant cells, an occasionally abundant stromal reticulin network and a high frequency of TP53 mutations. (WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Giant Cell Glioblastoma","conceptCode":"C4325","definition":"A rare histological variant of glioblastoma with a predominance of bizarre, multinucleated giant cells, an occasionally abundant stromal reticulin network, and a high frequency of TP53 mutations. (WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-007C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"ONEDATA","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4A2D2B82-B2C6-2EE0-E053-F662850A413A","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"ONEDATA","dateModified":"2017-03-07","deletedIndicator":"No"},{"value":"Gemistocytic astrocytoma, IDH-mutant","valueDescription":"Gemistocytic Astrocytoma, IDH-Mutant","ValueMeaning":{"publicId":"5698566","version":"1","preferredName":"Gemistocytic Astrocytoma, IDH-Mutant","longName":"5698566","preferredDefinition":"Gemistocytic astrocytoma carrying IDH mutations.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gemistocytic Astrocytoma, IDH-Mutant","conceptCode":"C129272","definition":"Gemistocytic astrocytoma carrying IDH mutations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A2D2B82-B2D3-2EE0-E053-F662850A413A","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4A2D2B82-B2EC-2EE0-E053-F662850A413A","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"ONEDATA","dateModified":"2017-03-07","deletedIndicator":"No"},{"value":"Epithelioid glioblastoma","valueDescription":"Epithelioid Glioblastoma","ValueMeaning":{"publicId":"5698568","version":"1","preferredName":"Epithelioid Glioblastoma","longName":"5698568","preferredDefinition":"An IDH-wildtype glioblastoma characterized by the presence of large epithelioid cells with abundant eosinophilic cytoplasm, vesicular chromatin, and prominent nucleoli.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epithelioid Glioblastoma","conceptCode":"C129293","definition":"An IDH-wildtype glioblastoma characterized by the presence of large epithelioid cells with abundant eosinophilic cytoplasm, vesicular chromatin, and prominent nucleoli.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A2D2B82-B2F9-2EE0-E053-F662850A413A","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4A2D2B82-B312-2EE0-E053-F662850A413A","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"ONEDATA","dateModified":"2017-03-07","deletedIndicator":"No"},{"value":"Diffuse midline glioma, H3 K27M-mutant","valueDescription":"Diffuse Midline Glioma, H3 K27M-Mutant","ValueMeaning":{"publicId":"5698570","version":"1","preferredName":"Diffuse Midline Glioma, H3 K27M-Mutant","longName":"5698570","preferredDefinition":"A childhood diffuse midline glioma characterized by the presence of histone H3 K27M mutation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diffuse Midline Glioma, H3 K27M-Mutant","conceptCode":"C129309","definition":"A diffuse midline glioma characterized by the presence of histone H3 K27M mutation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A2D2B82-B31F-2EE0-E053-F662850A413A","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4A2D2B82-B338-2EE0-E053-F662850A413A","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"ONEDATA","dateModified":"2017-03-07","deletedIndicator":"No"},{"value":"Diffuse astrocytoma, NOS","valueDescription":"Diffuse Astrocytoma, Not Otherwise Specified","ValueMeaning":{"publicId":"5698572","version":"1","preferredName":"Diffuse Astrocytoma, Not Otherwise Specified","longName":"5698572","preferredDefinition":"Diffuse astrocytoma in which there is insufficient information on the IDH genes status.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diffuse Astrocytoma, Not Otherwise Specified","conceptCode":"C129277","definition":"A central nervous system tumor with morphological features of diffuse astrocytoma in which there is insufficient information on the IDH genes status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A2D2B82-B345-2EE0-E053-F662850A413A","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4A2D2B82-B35E-2EE0-E053-F662850A413A","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"ONEDATA","dateModified":"2017-03-07","deletedIndicator":"No"},{"value":"Diffuse astrocytoma, IDH-wildtype","valueDescription":"Diffuse Astrocytoma, IDH-Wildtype","ValueMeaning":{"publicId":"5698574","version":"1","preferredName":"Diffuse Astrocytoma, IDH-Wildtype","longName":"5698574","preferredDefinition":"Diffuse astrocytoma lacking mutations in IDH1 or IDH2 genes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diffuse Astrocytoma, IDH-Wildtype","conceptCode":"C129274","definition":"Diffuse astrocytoma lacking mutations in IDH1 or IDH2 genes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A2D2B82-B36B-2EE0-E053-F662850A413A","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4A2D2B82-B384-2EE0-E053-F662850A413A","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"ONEDATA","dateModified":"2017-03-07","deletedIndicator":"No"},{"value":"Diffuse astrocytoma, IDH-mutant","valueDescription":"Diffuse Astrocytoma, IDH-Mutant","ValueMeaning":{"publicId":"5698576","version":"1","preferredName":"Diffuse Astrocytoma, IDH-Mutant","longName":"5698576","preferredDefinition":"Diffuse astrocytoma carrying IDH mutations.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Astrocytoma, IDH-Mutant, Grade 2","conceptCode":"C129271","definition":"IDH-mutant astrocytoma characterized by the presence of well-differentiated fibrillary glial cells diffusely infiltrating the central nervous system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A2D2B82-B391-2EE0-E053-F662850A413A","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4A2D2B82-B3AA-2EE0-E053-F662850A413A","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"ONEDATA","dateModified":"2017-03-07","deletedIndicator":"No"},{"value":"Anaplastic oligodendroglioma, NOS","valueDescription":"Anaplastic Oligodendroglioma, Not Otherwise Specified","ValueMeaning":{"publicId":"5698578","version":"1","preferredName":"Anaplastic Oligodendroglioma, Not Otherwise Specified","longName":"5698578","preferredDefinition":"An anaplastic oligodendroglioma in which there is insufficient information on the IDH genes and 1p/19q codeletion status.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anaplastic Oligodendroglioma, Not Otherwise Specified","conceptCode":"C129322","definition":"A central nervous system tumor with morphological features of anaplastic oligodendroglioma in which there is insufficient information on the IDH genes and 1p/19q codeletion status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A2D2B82-B3B7-2EE0-E053-F662850A413A","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4A2D2B82-B3D0-2EE0-E053-F662850A413A","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"ONEDATA","dateModified":"2017-03-07","deletedIndicator":"No"},{"value":"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted","valueDescription":"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted","ValueMeaning":{"publicId":"5698580","version":"1","preferredName":"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted","longName":"5698580","preferredDefinition":"An anaplastic oligodendroglioma carrying IDH gene family mutation and combined whole-arm losses of 1p and 19q (1p/19q codeletion).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted","conceptCode":"C129321","definition":"An anaplastic oligodendroglioma carrying IDH gene family mutation and combined whole-arm losses of 1p and 19q (1p/19q codeletion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A2D2B82-B3DD-2EE0-E053-F662850A413A","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4A2D2B82-B3F6-2EE0-E053-F662850A413A","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"ONEDATA","dateModified":"2017-03-07","deletedIndicator":"No"},{"value":"Anaplastic oligoastrocytoma, NOS","valueDescription":"Anaplastic Oligoastrocytoma, Not Otherwise Specified","ValueMeaning":{"publicId":"5698582","version":"1","preferredName":"Anaplastic Oligoastrocytoma, Not Otherwise Specified","longName":"5698582","preferredDefinition":"A diffuse anaplastic glioma characterized by the presence of both an astrocytic and an oligodendroglial component and the absence of information on the IDH genes status.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anaplastic Oligoastrocytoma, Not Otherwise Specified","conceptCode":"C129324","definition":"A central nervous system tumor with morphological features of anaplastic oligoastrocytoma in which there is insufficient information on the IDH genes status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A2D2B82-B403-2EE0-E053-F662850A413A","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4A2D2B82-B41C-2EE0-E053-F662850A413A","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"ONEDATA","dateModified":"2017-03-07","deletedIndicator":"No"},{"value":"Anaplastic astrocytoma, NOS","valueDescription":"Anaplastic Astrocytoma, Not Otherwise Specified","ValueMeaning":{"publicId":"5698584","version":"1","preferredName":"Anaplastic Astrocytoma, Not Otherwise Specified","longName":"5698584","preferredDefinition":"Anaplastic astrocytoma in which there is insufficient information on the IDH genes status.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anaplastic Astrocytoma, Not Otherwise Specified","conceptCode":"C129292","definition":"A central nervous system tumor with morphological features of anaplastic astrocytoma in which there is insufficient information on the IDH genes status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A2D2B82-B429-2EE0-E053-F662850A413A","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4A2D2B82-B442-2EE0-E053-F662850A413A","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"ONEDATA","dateModified":"2017-03-07","deletedIndicator":"No"},{"value":"Anaplastic astrocytoma, IDH-wildtype","valueDescription":"Anaplastic Astrocytoma, IDH-Wildtype","ValueMeaning":{"publicId":"5698586","version":"1","preferredName":"Anaplastic Astrocytoma, IDH-Wildtype","longName":"5698586","preferredDefinition":"Anaplastic astrocytoma lacking mutations in IDH1 or IDH2 genes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anaplastic Astrocytoma, IDH-Wildtype","conceptCode":"C129291","definition":"Anaplastic astrocytoma lacking mutations in IDH1 or IDH2 genes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A2D2B82-B44F-2EE0-E053-F662850A413A","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4A2D2B82-B468-2EE0-E053-F662850A413A","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"ONEDATA","dateModified":"2017-03-07","deletedIndicator":"No"},{"value":"Anaplastic astrocytoma, IDH-mutant","valueDescription":"Anaplastic Astrocytoma, IDH-Mutant","ValueMeaning":{"publicId":"5698588","version":"1","preferredName":"Anaplastic Astrocytoma, IDH-Mutant","longName":"5698588","preferredDefinition":"Anaplastic astrocytoma carrying IDH mutations.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Astrocytoma, IDH-Mutant, Grade 3","conceptCode":"C129290","definition":"IDH-mutant astrocytoma characterized by the presence of increased mitotic activity and anaplastic features.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A2D2B82-B475-2EE0-E053-F662850A413A","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4A2D2B82-B48E-2EE0-E053-F662850A413A","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"ONEDATA","dateModified":"2017-03-07","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2229718","version":"1","preferredName":"Name","preferredDefinition":"The words or language units by which a thing is known.","longName":"C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F6EF4E2B-76AE-72C1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-05-16","modifiedBy":"ONEDATA","dateModified":"2005-05-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A2D2B82-B1BA-2EE0-E053-F662850A413A","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"COOPERM","dateModified":"2017-03-10","changeDescription":"Created for ABTC-1601 Study in Rave. mc 3/7/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"WHO Classification","type":"Preferred Question Text","description":"WHO Classification","url":null,"context":"ABTC"}],"origin":"WHO:World Health Organization","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A2D81A4-D2D4-63E4-E053-F662850AA42C","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"COOPERM","dateModified":"2017-03-10","changeDescription":"Created for ABTC-1601 study in Rave. mc 3/7/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}